痴呆症护理研究和心理社会因素
Fernanda M de Faria1, Carolina Godoy2, Lucas Martins Teixeir3
1Federal University of São Paulo, São Paulo, Sao Paulo, Brazil.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
患有轻度痴呆症和年龄较低的老年人更有可能使用抗痴呆药物. 照顾者负担对药物使用有积极的影响,而非配偶照顾者与使用量较低有关.
科学领域:
- 老年学和制药科学 医学
- 临床痴呆症研究 临床痴呆症研究
背景情况:
- 研究了140名痴呆症患者及其照顾者,根据使用抗痴呆药物 (胆酶抑制剂和记忆剂) 分成组.
- 该研究探讨了影响老年痴呆症患者处方这些药物的因素.
研究的目的:
- 确定与痴呆症患者使用抗痴呆药物相关的社会人口统计和临床特征.
- 调查痴呆症严重程度,护理人员特征和药物处方模式之间的关系.
主要方法:
- 结构化的访谈和验证的尺度 (CDR,NPI-Q,JHDCNA 2.0,DEMQOL,Zarit尺度) 用于数据收集.
- 使用后勤回归分析来确定与抗痴呆药物使用相关的因素.
主要成果:
- 超过一半的痴呆症患者 (57.8%) 接受药理治疗,包括各种胆酶抑制剂 (ChEIs) 和记忆剂.
- 年轻的患者和患有轻度痴呆症 (CDR分数较低) 的患者更有可能使用这些药物.
- 较高的护理人员负担 (扎里特尺度) 与药物使用有积极的相关性,而非配偶护理人员与较低的药物使用有关.
结论:
- 患有较轻症和年龄较小的痴呆症患者更有可能接受药物治疗.
- 护理人员负担是与ChEIs和memantine的使用积极相关的重要因素.
- 照顾者的类型 (配偶与非配偶) 影响药物处方模式.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
相关概念视频
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
Psychological and Sociocultural Causes of Schizophrenia
438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
